Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 1,723 | 1,854 | 2,788 | 871 | 805 |
| Operating Income | -1,723 | -1,854 | -2,788 | -871 | -805 |
| Other Income | 7 | 5 | -19 | -159 | -761 |
| Pre-tax Income | -1,716 | -1,849 | -2,807 | -1,030 | -1,566 |
| Net Income Continuous | -1,716 | -1,849 | -2,807 | -1,030 | -1,566 |
| Net Income Discontinuous | -156 | 649 | -378 | -68 | -114 |
| Net Income | $-1,872 | $-1,200 | $-3,185 | $-1,098 | $-1,680 |
| EPS Basic Total Ops | -437.06 | -349.65 | -874.13 | -349.65 | -524.48 |
| EPS Basic Continuous Ops | -454.39 | -524.48 | -699.30 | -349.65 | -524.48 |
| EPS Basic Discontinuous Ops | -41.31 | 174.83 | -130.75 | -21.16 | -35.74 |
| EPS Diluted Total Ops | -437.06 | -349.65 | -874.13 | -349.65 | -524.48 |
| EPS Diluted Continuous Ops | -454.39 | -524.48 | -699.30 | -349.65 | -524.48 |
| EPS Diluted Discontinuous Ops | -41.31 | 174.83 | -130.75 | -21.16 | -35.74 |
| EBITDA(a) | $-1,704 | $-1,834 | $-2,720 | $-839 | $-784 |